Lucy C. Okell

ORCID, self-asserted

ORCID 0000-0001-7202-6873

Publications

Citations

192

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

21 works in the graph, newest first.

Target product profiles of laboratory and data analytical frameworks for genotyping to monitor antimalarial efficacy
2026PLOS Global Public HealthJournalOpen access0 citations10.1371/journal.pgph.0006500
Implementation determinants of rapid diagnostic tests for fever management in sub-Saharan Africa: a mixed-studies systematic review
2026Nature CommunicationsJournalOpen access0 citations10.1038/s41467-026-72915-6
Quantifying relative health impact across Gavi, the Vaccine Alliance's portfolio in 117 countries at the subregional level: a modelling study
2026The LancetJournalOpen access4 citations10.1016/s0140-6736(26)00555-6
Mapping the prevalence of molecular markers of Plasmodium falciparum artemisinin partial resistance in Africa: a systematic review and spatiotemporal modelling study
2026The Lancet Infectious DiseasesJournalOpen access0 citations10.1016/s1473-3099(26)00237-9
Validating HIV Viral Suppression Threshold Adjustments for Comparable Estimates Using Data From Nationally Representative Household Surveys in Sub-Saharan Africa
2026JAIDS Journal of Acquired Immune Deficiency SyndromesJournalOpen access0 citations10.1097/qai.0000000000003878
Sensitive near point-of-care detection of asymptomatic and submicroscopic Plasmodium falciparum infections in African endemic countries
2025Nature CommunicationsJournalOpen access5 citations10.1038/s41467-025-64027-4
Impact of dhps mutations on sulfadoxine-pyrimethamine protective efficacy and implications for malaria chemoprevention
2025Nature CommunicationsJournalOpen access12 citations10.1038/s41467-025-58326-z
Selection of Plasmodium falciparum kelch13 mutations in Uganda in comparison with southeast Asia: a modelling study
2025The Lancet MicrobeJournalOpen access12 citations10.1016/j.lanmic.2024.101027
Examining gender and ethnic disparities in scientific authorship to promote a culture of equity, diversity and inclusion at a university school of public health
2025Proceedings of the Royal Society B Biological SciencesJournalOpen accessSenior author1 citations10.1098/rspb.2025.0313
Toward Setting Minimum and Optimal Data to Report for Malaria Molecular Surveillance with Targeted Sequencing: The “What” and “Why”
2025American Journal of Tropical Medicine and HygieneJournalOpen access1 citations10.4269/ajtmh.25-0147
Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a two-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus artesunate monotherapy among asymptomatic children 3–5 years of age in Zambia
2025BMC Infectious DiseasesJournalOpen access0 citations10.1186/s12879-025-11975-3
HIV risk behaviour, viraemia, and transmission across HIV cascade stages including low-level viremia: Analysis of 14 cross-sectional population-based HIV Impact Assessment surveys in sub-Saharan Africa
2024PLOS Global Public HealthJournalOpen access4 citations10.1371/journal.pgph.0003030
High Frequency of Artemisinin Partial Resistance Mutations in the Great Lakes Region Revealed Through Rapid Pooled Deep Sequencing
2024The Journal of Infectious DiseasesJournalOpen access32 citations10.1093/infdis/jiae475
Cost of treating severe malaria in children in Africa: a systematic literature review
2024Malaria JournalJournalOpen accessSenior author5 citations10.1186/s12936-024-05173-w
Measuring protective efficacy and quantifying the impact of drug resistance: A novel malaria chemoprevention trial design and methodology
2024PLoS MedicineJournalOpen accessSenior author16 citations10.1371/journal.pmed.1004376
Parasite clearance and protection from Plasmodium falciparum infection (PCPI): a three-arm, parallel, double-blinded, placebo-controlled, randomised trial of presumptive sulfadoxine-pyrimethamine versus sulfadoxine-pyrimethamine plus amodiaquine versus artesunate monotherapy among asymptomatic children 3–5 years of age in Cameroon
2024BMC Infectious DiseasesJournalOpen access6 citations10.1186/s12879-024-09868-y
Projected health impact of post-discharge malaria chemoprevention among children with severe malarial anaemia in Africa
2023Nature CommunicationsJournalOpen accessFirst authorCorresponding16 citations10.1038/s41467-023-35939-w
Estimating the burden of severe malarial anaemia and access to hospital care in East Africa
2023Nature CommunicationsJournalOpen accessSenior author9 citations10.1038/s41467-023-41275-w
Using mortuary and burial data to place COVID-19 in Lusaka, Zambia within a global context
2023Nature CommunicationsJournalOpen access13 citations10.1038/s41467-023-39288-6
Predictors and consequences of HIV status disclosure to adolescents living with HIV in Eastern Cape, South Africa: a prospective cohort study
2022Journal of the International AIDS SocietyJournalOpen access12 citations10.1002/jia2.25910
Impact of seasonal malaria chemoprevention on prevalence of malaria infection in malaria indicator surveys in Burkina Faso and Nigeria
2022BMJ Global HealthJournalOpen accessSenior author44 citations10.1136/bmjgh-2021-008021